Blood Banking (Testing)
"Cost-Effectiveness of Expanded Human Immunodeficiency Virus-Testing Protocols for Donated Blood."
Published in Blood Weekly, March 17th, 1997
According to the authors' abstract of an article published in Transfusion, "Background: This study was designed to estimate the cost-effectiveness of expanding the human immunodeficiency virus (HIV)-testing protocol for donated blood beyond screening for HIV antibodies to further reduce the risk of HIV transmission through transfusion. Study Design and Methods: A Markov decision analysis model was developed to estimate the cost-effectiveness of HIV antibody testing (at a cost of $5/unit) and of adding to that protocol a second HIV test, either plasma p24 antigen detection or RNA polymerase chain reaction (PGR) (at costs of $5/unit and $8/unit, respectively). Test...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1997-03-17)
More Articles from Blood Weekly
- Blood Banking
Preapheresis Progenitor Counts Are Insufficient to Accurately Predict Yields - Blood Banking (HIV Testing)
p24 Antigen or RNA PCR Testing Adds Little to Blood Safety - Blood Banking (Platelet Concentrates)
Refrigerated System May Improve Transfusion Safety - Blood Banking (Safety)
Hold on Clotting Factor Lifted After No HIV Found - At-Risk Populations
HIV Risk High, Infection Rate Low in Marginalized Populations - Diagnostics (HIV)
Control Peptide Is Essential for Accurate Results - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
